These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 30615403)
1. [The development and comparative approbation of methods of increasing sensitivity of detection of mutation V617F in gene JAK2 by pyro-sequencing]. Dunaeva EA; Mironov KO; Subbotina TN; Olkhovsky IA; Shipulin GA Klin Lab Diagn; 2017 Feb; 62(2):125-8. PubMed ID: 30615403 [TBL] [Abstract][Full Text] [Related]
2. Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR. Kinz E; Leiherer A; Lang AH; Drexel H; Muendlein A Int J Lab Hematol; 2015 Apr; 37(2):217-24. PubMed ID: 24963593 [TBL] [Abstract][Full Text] [Related]
3. [Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening]. Chae H; Lee JH; Lim J; Jung SW; Kim M; Kim Y; Han K; Cho BS; Cho SG; Lee JW; Min WS Korean J Lab Med; 2009 Jun; 29(3):243-8. PubMed ID: 19571623 [TBL] [Abstract][Full Text] [Related]
4. The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms. Borowczyk M; Wojtaszewska M; Lewandowski K; Gil L; Lewandowska M; Lehmann-Kopydłowska A; Kroll-Balcerzak R; Balcerzak A; Iwoła M; Michalak M; Komarnicki M Thromb Res; 2015 Feb; 135(2):272-80. PubMed ID: 25559461 [TBL] [Abstract][Full Text] [Related]
6. [Establishment of a system for rapid detection of JAK2 V617F mutation in myeloproliferative diseases]. Zhang Q; Zhang Y; Xu X; Zhou W; Fan X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):980-984. PubMed ID: 31598940 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a tetra-primer amplification refractory mutation system-polymerase chain reaction combined with melting analysis-assay for clinical JAK2 V617F mutation detection. Liu W; Hu T; Chen Y; Zhang X; Gu X; Guan M Mol Diagn Ther; 2014 Oct; 18(5):579-85. PubMed ID: 25015634 [TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms. Lee E; Lee KJ; Park H; Chung JY; Lee MN; Chang MH; Yoo J; Lee H; Kong SY; Eom HS Ann Lab Med; 2018 Mar; 38(2):147-154. PubMed ID: 29214759 [TBL] [Abstract][Full Text] [Related]
9. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation. Tan AY; Westerman DA; Dobrovic A Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995 [TBL] [Abstract][Full Text] [Related]
10. Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders. Chen Q; Lu P; Jones AV; Cross NC; Silver RT; Wang YL J Mol Diagn; 2007 Apr; 9(2):272-6. PubMed ID: 17384221 [TBL] [Abstract][Full Text] [Related]
11. [Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases]. Olkhovskiy IA; Gorbenko AS; Stolyar MA; Grischenko DA; Tkachenko OA; Martsinkevich TL Ter Arkh; 2019 Jul; 91(7):25-28. PubMed ID: 32598732 [TBL] [Abstract][Full Text] [Related]
12. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting. Lin CY; Ho CM; Tamamyan G; Yang SF; Peng CT; Chang JG J Clin Lab Anal; 2016 Nov; 30(6):838-844. PubMed ID: 27169616 [TBL] [Abstract][Full Text] [Related]
13. Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR. Waterhouse M; Follo M; Pfeifer D; von Bubnoff N; Duyster J; Bertz H; Finke J Ann Hematol; 2016 Apr; 95(5):739-44. PubMed ID: 26931113 [TBL] [Abstract][Full Text] [Related]
14. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211 [TBL] [Abstract][Full Text] [Related]
15. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis. Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011 [TBL] [Abstract][Full Text] [Related]
16. [The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis]. Zhang SJ; Li WD; Song JH; Xu W; Qiu HX; Li JY Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2109-12. PubMed ID: 17988529 [TBL] [Abstract][Full Text] [Related]
17. Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases. Horn T; Kremer M; Dechow T; Pfeifer WM; Geist B; Perker M; Duyster J; Quintanilla-Martinez L; Fend F J Mol Diagn; 2006 Jul; 8(3):299-304. PubMed ID: 16825501 [TBL] [Abstract][Full Text] [Related]
18. JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia. Kaeda J; Bonamino M; Ayres-Silva J; Solza C; Ringel F; Blau O; Daumas A; Oberender C; Dörken B; le Coutre P; Zalcberg I Leuk Lymphoma; 2014 Jan; 55(1):128-35. PubMed ID: 23607255 [TBL] [Abstract][Full Text] [Related]
19. JAK2 V617F mutation can be reliably detected in serum using droplet digital PCR. Nystrand CF; Ghanima W; Waage A; Jonassen CM Int J Lab Hematol; 2018 Apr; 40(2):181-186. PubMed ID: 29150911 [TBL] [Abstract][Full Text] [Related]
20. Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations. Bousquet M; Le Guellec S; Quelen C; Rigal-Huguet F; Delsol G; Brousset P Hum Pathol; 2006 Nov; 37(11):1458-64. PubMed ID: 16949922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]